Vanderbilt-Ingram Cancer Center

Clinical Trial VICCGI0721

Title

Vanderbilt Hereditary Colorectal Cancer Registry

Principal Investigator(s)

Timothy Geiger

Details

• Protocol No. VICCGI0721
• Open Date: 01/09/2007
• Staging: NA
• Age Group: Adults
• Scope: Local
• Objective: To identify patients and their family members who either have a hereditary colorectal cancer or polyposis syndrome or are at high risk for developing hereditary colorectal cancer.
• Disease Sites: Gastrointestinal; Colon; Rectal
• Therapies: None Specified
• Drugs: None Specified
• Participating Institutions: Vanderbilt University
• National Clinical Trial ID: NCT00675636
• Secondary Protocol No: Not Specified

Description

Eligibility

Criteria
 DISEASE CHARACTERISTICS:

 • Meets any of the following criteria:

 • Patients and family members with a known hereditary colorectal cancer or polyposis syndrome

 • Patients who meet Amsterdam I, II, or Bethesda criteria

 • Patients with a family history suggestive of a hereditary colorectal or polyposis syndrome

 • Patients diagnosed with colorectal cancer at < 50 years old

 • Patients are identified through surgical, oncological, gynecological, and gastrointestinal programs, as well as outside referrals, self referral, and the Vanderbilit Tumor Registry

 PATIENT CHARACTERISTICS:

 • See Disease Characteristics

 PRIOR CONCURRENT THERAPY:

 • Not specified 

Learn More

• Call toll-free number: 1-800-811-8480
• Use our Online self–referral form
• Print this page for your doctor